Qube Research & Technologies LTD Astrazeneca PLC Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 223,630 shares of AZN stock, worth $16.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
223,630
Previous 590,541
62.13%
Holding current value
$16.5 Million
Previous $38.7 Million
57.52%
% of portfolio
0.02%
Previous 0.05%
Shares
19 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.22 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.01 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...